A randomized study of temozolomide (TMX) alone, with interferon-alpha (TMZ-IFN) or with thalidomide (TMZ-THL) in metastatic malignant melanoma (MMM)

S Danson, A Arance, P Lorigan, A Clamp, J Hodgetts, L Lomax, N Thatcher, Mr Middleton

Research output: Other contributionpeer-review

Abstract

38th Annual Meeting of the American Society of Clinical Oncology; 18-21 May 2002; Orlando, Florida, USA
Original languageEnglish
Volume21 (Pt 1)
Publication statusPublished - 2002

Publication series

NameProceedings of the american society of clinical oncology
Volume21 (Pt 1)

Fingerprint

Dive into the research topics of 'A randomized study of temozolomide (TMX) alone, with interferon-alpha (TMZ-IFN) or with thalidomide (TMZ-THL) in metastatic malignant melanoma (MMM)'. Together they form a unique fingerprint.

Cite this